Vertex Pharmaceuticals (VRTX) EBIT Margin (2009 - 2026)
Vertex Pharmaceuticals' quarterly EBIT Margin came in at 38.1% in Q1 2026, up 1536.0% year-on-year from 2.33% in Q1 2025, and up 0.8% quarter-over-quarter from 37.8% in Q4 2025.
Vertex Pharmaceuticals has reported EBIT Margin for 18 years, with the latest figure at 38.1% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 1536.0% year-over-year to 38.1%; the trailing twelve-month figure through Mar 2026 stood at 38.31% (up 4500.0% YoY), and the FY2025 full-year result was 34.77%, up 3689.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 38.1%, up from 37.8% in the prior quarter.
- The five-year high for EBIT Margin was 50.37% in Q2 2022, with the low at 132.85% in Q2 2024.
- Average EBIT Margin over 5 years is 29.95%, with a median of 39.26% recorded in 2023.
- Year-over-year, EBIT Margin slumped 17402 bps in 2024 and soared 17168 bps in 2025.
- Tracing VRTX's EBIT Margin over 5 years: stood at 44.88% in 2022, then dropped by 13 bps to 39.26% in 2023, then dropped by 10 bps to 35.23% in 2024, then advanced by 7 bps to 37.8% in 2025, then rose by 1 bps to 38.1% in 2026.
- The last three EBIT Margin figures came in at 38.1% (Q1 2026), 37.8% (Q4 2025), and 38.56% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.10% |
| Dec 31, 2025 | 37.80% |
| Sep 30, 2025 | 38.56% |
| Jun 30, 2025 | 38.83% |
| Mar 31, 2025 | 22.75% |
| Dec 31, 2024 | 35.23% |
| Sep 30, 2024 | 40.27% |
| Jun 30, 2024 | -132.85% |
| Mar 31, 2024 | 42.35% |
| Dec 31, 2023 | 39.26% |
| Sep 30, 2023 | 41.80% |
| Jun 30, 2023 | 41.17% |
| Mar 31, 2023 | 32.80% |
| Dec 31, 2022 | 44.88% |
| Sep 30, 2022 | 48.27% |
| Jun 30, 2022 | 50.37% |
| Mar 31, 2022 | 49.63% |
| Dec 31, 2021 | 42.35% |
| Sep 30, 2021 | 53.15% |
| Jun 30, 2021 | -2.11% |
| Mar 31, 2021 | 51.49% |
| Dec 31, 2020 | 45.82% |
| Sep 30, 2020 | 43.70% |
| Jun 30, 2020 | 47.10% |
| Mar 31, 2020 | 47.54% |
| Dec 31, 2019 | 353.96% |
| Sep 30, 2019 | 10.46% |
| Jun 30, 2019 | 28.68% |
| Mar 31, 2019 | 32.25% |
| Dec 31, 2018 | 14.68% |
| Sep 30, 2018 | 26.21% |
| Jun 30, 2018 | 22.98% |
| Mar 31, 2018 | 20.12% |
| Dec 31, 2017 | 19.30% |
| Sep 30, 2017 | -56.39% |
| Jun 30, 2017 | 9.69% |
| Mar 31, 2017 | 37.89% |
| Dec 31, 2016 | 8.64% |
| Sep 30, 2016 | -4.57% |
| Jun 30, 2016 | 0.79% |
| Mar 31, 2016 | -3.60% |
| Dec 31, 2015 | -13.21% |
| Sep 30, 2015 | -23.15% |
| Jun 30, 2015 | -103.06% |
| Mar 31, 2015 | -131.41% |
| Dec 31, 2014 | -106.27% |
| Sep 30, 2014 | -103.72% |
| Jun 30, 2014 | -147.60% |
| Mar 31, 2014 | -182.39% |
| Dec 31, 2013 | -7.98% |
| Sep 30, 2013 | -55.73% |
| Jun 30, 2013 | -18.46% |
| Mar 31, 2013 | -130.69% |
| Dec 31, 2012 | -23.20% |
| Sep 30, 2012 | -0.32% |
| Jun 30, 2012 | -2.57% |
| Mar 31, 2012 | 24.42% |
| Dec 31, 2011 | 39.75% |
| Sep 30, 2011 | 51.41% |
| Mar 31, 2011 | -217.07% |
| Dec 31, 2010 | -254.31% |
| Sep 30, 2010 | -838.78% |
| Jun 30, 2010 | -536.25% |
| Mar 31, 2010 | -714.62% |
| Dec 31, 2009 | -432.94% |
| Sep 30, 2009 | -593.95% |
| Jun 30, 2009 | -824.42% |
| Mar 31, 2009 | -675.14% |